Orientation dependence of trinucleotide CAG repeat instability in Saccharomyces cerevisiae.

Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol Mol Biol Rev (1999) 19.25

Microsatellite instability in yeast: dependence on the length of the microsatellite. Genetics (1997) 3.51

Comparative genomics and molecular dynamics of DNA repeats in eukaryotes. Microbiol Mol Biol Rev (2008) 3.35

Stability of a CTG/CAG trinucleotide repeat in yeast is dependent on its orientation in the genome. Mol Cell Biol (1997) 1.95

Orientation-dependent and sequence-specific expansions of CTG/CAG trinucleotide repeats in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1998) 1.90

Triplet repeats form secondary structures that escape DNA repair in yeast. Proc Natl Acad Sci U S A (1999) 1.83

Advances in mechanisms of genetic instability related to hereditary neurological diseases. Nucleic Acids Res (2005) 1.77

Recombination-induced CAG trinucleotide repeat expansions in yeast involve the MRE11-RAD50-XRS2 complex. EMBO J (2000) 1.56

Mutations in yeast replication proteins that increase CAG/CTG expansions also increase repeat fragility. Mol Cell Biol (2003) 1.41

Huntington disease expansion mutations in humans can occur before meiosis is completed. Proc Natl Acad Sci U S A (2003) 1.35

Instability of CAG and CTG trinucleotide repeats in Saccharomyces cerevisiae. Mol Cell Biol (1997) 1.32

SRS2 and SGS1 prevent chromosomal breaks and stabilize triplet repeats by restraining recombination. Nat Struct Mol Biol (2009) 1.32

Trinucleotide repeats are clustered in regulatory genes in Saccharomyces cerevisiae. Genetics (2000) 1.32

Meiotic instability of CAG repeat tracts occurs by double-strand break repair in yeast. Proc Natl Acad Sci U S A (2000) 1.30

Stability of the human fragile X (CGG)(n) triplet repeat array in Saccharomyces cerevisiae deficient in aspects of DNA metabolism. Mol Cell Biol (1999) 1.24

ATR protects the genome against CGG.CCG-repeat expansion in Fragile X premutation mice. Nucleic Acids Res (2007) 1.23

The impact of lagging strand replication mutations on the stability of CAG repeat tracts in yeast. Genetics (2000) 1.20

Nuclease-deficient FEN-1 blocks Rad51/BRCA1-mediated repair and causes trinucleotide repeat instability. Mol Cell Biol (2003) 1.17

The effect of DNA replication mutations on CAG tract stability in yeast. Genetics (1999) 1.14

Replication-mediated instability of the GAA triplet repeat mutation in Friedreich ataxia. Nucleic Acids Res (2004) 1.10

Cis-elements governing trinucleotide repeat instability in Saccharomyces cerevisiae. Genetics (2001) 1.09

Genetic instability induced by overexpression of DNA ligase I in budding yeast. Genetics (2005) 0.98

Increased instability of human CTG repeat tracts on yeast artificial chromosomes during gametogenesis. Mol Cell Biol (1999) 0.97

Long CTG tracts from the myotonic dystrophy gene induce deletions and rearrangements during recombination at the APRT locus in CHO cells. Mol Cell Biol (2003) 0.97

Repeat instability during DNA repair: Insights from model systems. Crit Rev Biochem Mol Biol (2015) 0.97

Mapping the polarity of changes that occur in interrupted CAG repeat tracts in yeast. Mol Cell Biol (1998) 0.96

Proofreading and secondary structure processing determine the orientation dependence of CAG x CTG trinucleotide repeat instability in Escherichia coli. Genetics (2007) 0.94

Interactions among DNA ligase I, the flap endonuclease and proliferating cell nuclear antigen in the expansion and contraction of CAG repeat tracts in yeast. Genetics (2005) 0.94

Selectable system for monitoring the instability of CTG/CAG triplet repeats in mammalian cells. Mol Cell Biol (2003) 0.94

Transcription influences the types of deletion and expansion products in an orientation-dependent manner from GAC*GTC repeats. Nucleic Acids Res (2004) 0.94

Mechanistic features of CAG*CTG repeat contractions in cultured cells revealed by a novel genetic assay. Nucleic Acids Res (2005) 0.93

Altered replication in human cells promotes DMPK (CTG)(n) · (CAG)(n) repeat instability. Mol Cell Biol (2012) 0.92

Both CAG repeats and inverted DNA repeats stimulate spontaneous unequal sister-chromatid exchange in Saccharomyces cerevisiae. Nucleic Acids Res (2004) 0.90

DNA triplet repeat expansion and mismatch repair. Annu Rev Biochem (2015) 0.88

DNA elements important for CAG*CTG repeat thresholds in Saccharomyces cerevisiae. Nucleic Acids Res (2004) 0.86

CAG*CTG repeat instability in cultured human astrocytes. Nucleic Acids Res (2006) 0.85

Suppression of a DNA polymerase delta mutation by the absence of the high mobility group protein Hmo1 in Saccharomyces cerevisiae. Curr Genet (2009) 0.81

Meiotic alterations in CAG repeat tracts. Genetics (2001) 0.80

Effects of sequence on repeat expansion during DNA replication. Nucleic Acids Res (2003) 0.79

Long CAG/CTG repeats in mice. Mamm Genome (1998) 0.78

Effects of Replication and Transcription on DNA Structure-Related Genetic Instability. Genes (Basel) (2017) 0.76

MSH3 Promotes Dynamic Behavior of Trinucleotide Repeat Tracts In Vivo. Genetics (2015) 0.75

Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell (1992) 12.74

Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature (1993) 10.95

Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science (1992) 9.32

An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science (1992) 8.20

Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet (1993) 7.97

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet (1994) 7.07

Instability of simple sequence DNA in Saccharomyces cerevisiae. Mol Cell Biol (1992) 4.46

Trinucleotide repeats that expand in human disease form hairpin structures in vitro. Cell (1995) 4.35

The ADE2 gene from Saccharomyces cerevisiae: sequence and new vectors. Gene (1990) 3.60

Expansion and deletion of CTG repeats from human disease genes are determined by the direction of replication in E. coli. Nat Genet (1995) 2.99

SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell (1995) 2.96

Inverted DNA repeats: a source of eukaryotic genomic instability. Mol Cell Biol (1993) 2.30

Mitotic gene conversion lengths, coconversion patterns, and the incidence of reciprocal recombination in a Saccharomyces cerevisiae plasmid system. Mol Cell Biol (1986) 2.27

Replication slippage between distant short repeats in Saccharomyces cerevisiae depends on the direction of replication and the RAD50 and RAD52 genes. Mol Cell Biol (1995) 2.21

Isolation of the centromere-linked CDC10 gene by complementation in yeast. Proc Natl Acad Sci U S A (1980) 2.18

Transposon Tn5 excision in yeast: influence of DNA polymerases alpha, delta, and epsilon and repair genes. Proc Natl Acad Sci U S A (1992) 1.97

Instability of a plasmid-borne inverted repeat in Saccharomyces cerevisiae. Genetics (1993) 1.35

DNA CTG triplet repeats involved in dynamic mutations of neurologically related gene sequences form stable duplexes. Nucleic Acids Res (1995) 1.20

The stabilization of repetitive tracts of DNA by variant repeats requires a functional DNA mismatch repair system. Cell (1995) 1.12

The effects of trinucleotide repeats found in human inherited disorders on palindrome inviability in Escherichia coli suggest hairpin folding preferences in vivo. Genetics (1995) 1.10

Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice. Nat Genet (1995) 1.05

Molecular cloning, characterization and analysis of the regulation of the ARO2 gene, encoding chorismate synthase, of Saccharomyces cerevisiae. Mol Microbiol (1991) 0.89

[Cloning of the ADE2 gene of Saccharomyces cerevisiae and localization of the ARS-sequence]. Genetika (1987) 0.88

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell (1988) 12.69

Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev (1994) 8.92

Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell (1997) 8.28

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell (1993) 7.19

Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell (1998) 6.73

Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell (1991) 6.55

The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell (1989) 6.43

Immunoaffinity chromatography of proteins. Methods Enzymol (1974) 6.40

Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell (1997) 5.92

Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science (2001) 5.58

E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell (1996) 5.26

Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem (1996) 5.15

Binding and modulation of p53 by p300/CBP coactivators. Nature (1997) 5.12

Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci U S A (1994) 5.11

The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell (1992) 5.05

BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell (2001) 5.05

T antigen repression of SV40 early transcription from two promoters. Cell (1981) 4.83

An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci U S A (1996) 4.57

Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev (1992) 4.56

A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature (1995) 4.40

In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature (2000) 4.38

The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell (1991) 4.24

Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell (1994) 4.01

Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Lincoln maps to chromosome 11. Nat Genet (1994) 3.89

Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature (1996) 3.88

SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell (1989) 3.88

Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol Cell (1998) 3.86

Genetic analysis of BRCA1 function in a defined tumor cell line. Mol Cell (1999) 3.83

Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med (2000) 3.72

Mapping of SV40 DNA replication origin region binding sites for the SV40 T antigen by protection against exonuclease III digestion. Cell (1980) 3.62

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell (1990) 3.61

ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature (2000) 3.48

Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell (1991) 3.47

The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc Natl Acad Sci U S A (1996) 3.43

Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell (2001) 3.43

Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature (1995) 3.39

lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cells. Cell (1987) 3.33

Infectious C-type virus isolated from a baboon placenta. Nature (1974) 3.32

Stringent regulation of stably integrated chloramphenicol acetyl transferase genes by E. coli lac repressor in monkey cells. Cell (1988) 3.29

p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell (1998) 3.27

Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev (1996) 3.24

Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev (2000) 3.24

E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell (1994) 3.24

Radioimmunoassay of mammalian type C viral proteins. I. Species specific reactions of murine and feline viruses. J Immunol (1972) 3.23

The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell (1990) 3.19

The p400 complex is an essential E1A transformation target. Cell (2001) 3.05

E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev (1994) 3.05

Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev (1995) 3.02

An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120. Cell (1989) 2.78

Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell (1995) 2.70

Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci U S A (1995) 2.70

Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science (1993) 2.70

The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Dev (1996) 2.58

TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell (1993) 2.57

Control of Saccharomyces cerevisiae 2microN DNA replication by cell division cycle genes that control nuclear DNA replication. J Mol Biol (1977) 2.55

BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci U S A (1997) 2.55

Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev (1999) 2.51

E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol Cell (2000) 2.48

Identification of regions of the SV40 genome which contain preferred SV40 T antigen-binding sites. Cell (1976) 2.47

Association of p300 and CBP with simian virus 40 large T antigen. Mol Cell Biol (1996) 2.40

Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science (1992) 2.39

Effect of limited homology on gene conversion in a Saccharomyces cerevisiae plasmid recombination system. Mol Cell Biol (1988) 2.37

Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell Biol (1993) 2.37

Relationship of oligomerization to enzymatic and DNA-binding properties of the SV40 large T antigen. Cell (1982) 2.35

Thermolabile T (tumor) antigen from cells transformed by a temperature-sensitive mutant of simian virus 40. Proc Natl Acad Sci U S A (1975) 2.32

Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol Cell Biol (1990) 2.27

Mitotic gene conversion lengths, coconversion patterns, and the incidence of reciprocal recombination in a Saccharomyces cerevisiae plasmid system. Mol Cell Biol (1986) 2.27

Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature (1998) 2.25

The subcellular localization of E2F-4 is cell-cycle dependent. Proc Natl Acad Sci U S A (1997) 2.24

A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting. Genes Dev (1998) 2.19

Interaction of partially purified simian virus 40 T antigen with circular viral DNA molecules. Proc Natl Acad Sci U S A (1975) 2.17

Consensus topography in the ATP binding site of the simian virus 40 and polyomavirus large tumor antigens. Proc Natl Acad Sci U S A (1987) 2.15

Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science (1992) 2.13

SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen. Cell (1987) 2.13

Radioimmunoassay of mammalian type C viral proteins. 3. Detection of viral antigen in normal murine cells and tissues. J Exp Med (1973) 2.13

Expansions of CAG repeat tracts are frequent in a yeast mutant defective in Okazaki fragment maturation. Hum Mol Genet (1998) 2.06

Endogenous type C virus from a cat cell clone with properties distinct from previously described feline type C virus. Virology (1973) 2.05

Inheritance of the 2 micrometer m DNA plasmid from Saccharomyces. Genetics (1977) 2.01

trans-activation of RNA polymerase II and III promoters by SV40 small t antigen. Cell (1988) 1.98

The transcription factor E2F-1 is a downstream target of RB action. Mol Cell Biol (1995) 1.97

The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc Natl Acad Sci U S A (1992) 1.94

Location of BRCA1 in human breast and ovarian cancer cells. Science (1996) 1.88

Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci U S A (1995) 1.86

Partial purification and characterization of the SV40 T antigen. Cell (1974) 1.81

Isolation of a condensed, intracellular form of the 2-micrometer DNA plasmid of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1979) 1.81

SV40 T antigen: partial purification and properties. Cold Spring Harb Symp Quant Biol (1975) 1.80

Mammalian cells in culture frequently release type C viruses. Science (1973) 1.79

Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc Natl Acad Sci U S A (1998) 1.77

The simian virus 40 large T antigen. A lot packed into a little. Mol Biol Med (1987) 1.77

Role of small t antigen in the acute transforming activity of SV40. Cell (1982) 1.76

p19ARF targets certain E2F species for degradation. Proc Natl Acad Sci U S A (2001) 1.75

Protein kinase activity associated with simian virus 40 T antigen. Proc Natl Acad Sci U S A (1979) 1.72

Deoxyribonucleic acid polymerase III of Escherichia coli. Purification and properties. J Biol Chem (1975) 1.72

Synthesis of simian virus 40 t antigen in Escherichia coli. Proc Natl Acad Sci U S A (1979) 1.70

Measurements of the molecular size of the simian virus 40 large T antigen. J Virol (1978) 1.70

A recombinant murine retrovirus for simian virus 40 large T cDNA transforms mouse fibroblasts to anchorage-independent growth. J Virol (1986) 1.68

Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development. Proc Natl Acad Sci U S A (2001) 1.67

Biological and biochemical studies of cells transformed by simian virus 40 temperature-sensitive gene A mutants and A mutant revertants. J Virol (1977) 1.64

Purification of biologically active simian virus 40 small tumor antigen. Proc Natl Acad Sci U S A (1983) 1.61

Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc Natl Acad Sci U S A (1990) 1.57